Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ANNORA PHARMA

  • FDA Approval
  • Feb. 07, 2024, 09:36 UTC
  • 47
  • 0 comments

FDA approve MESALAMINE

Comment Full text

ACS DOBFAR

  • FDA Approval
  • Feb. 07, 2024, 09:36 UTC
  • 44
  • 0 comments

FDA approve CILASTATIN SODIUM; IMIPENEM

Comment Full text

GENZYME

  • FDA Approval
  • Feb. 07, 2024, 09:36 UTC
  • 47
  • 0 comments

FDA approve AGALSIDASE BETA

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Feb. 07, 2024, 09:36 UTC
  • 46
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text

MYLAN

  • FDA Approval
  • Feb. 07, 2024, 09:36 UTC
  • 45
  • 0 comments

FDA approve SERTRALINE HYDROCHLORIDE

Comment Full text

PHARMASCIENCE INC

  • FDA Approval
  • Feb. 06, 2024, 20:06 UTC
  • 51
  • 0 comments

FDA approve PALIPERIDONE PALMITATE

Comment Full text

LAURUS LABS LTD

  • FDA Approval
  • Feb. 06, 2024, 17:49 UTC
  • 46
  • 0 comments

FDA approve BICTEGRAVIR;EMTRICITABINE;TENOFOVIR ALAFENAMIDE

Comment Full text

IMPAX LABS

  • FDA Approval
  • Feb. 06, 2024, 09:40 UTC
  • 45
  • 0 comments

FDA approve CHLOROQUINE PHOSPHATE

Comment Full text

BARR

  • FDA Approval
  • Feb. 06, 2024, 09:40 UTC
  • 45
  • 0 comments

FDA approve DROSPIRENONE; ETHINYL ESTRADIOL

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Feb. 06, 2024, 09:40 UTC
  • 41
  • 0 comments

FDA approve ESCITALOPRAM OXALATE

Comment Full text
  • Previous
  • 558
  • 559
  • 560
  • 561
  • 562
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328519)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183603)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin